Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial

IMPORTANCE: Cell-free DNA (cfDNA) tests are increasingly being offered to women in the first trimester of pregnancies at a high risk of trisomy 21 to decrease the number of required invasive fetal karyotyping procedures and their associated miscarriages. The effect of this strategy has not been eval...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA
Autors principals: Malan, Valérie, Bussières, Laurence, Winer, Norbert, Jais, Jean-Philippe, Baptiste, Amandine, Le Lorc’h, Marc, Elie, Caroline, O’Gorman, Neil, Fries, Nicolas, Houfflin-Debarge, Véronique, Sentilhes, Loic, Vekemans, Michel, Ville, Yves, Salomon, Laurent J.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2018
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583003/
https://ncbi.nlm.nih.gov/pubmed/30120476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.9396
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars